Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.91 USD
-0.04 (-2.05%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.88 -0.03 (-1.57%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2025
Time: -- |
9/2025 | $-0.13 | 6.49% |
Earnings Summary
For their last quarter, Aclaris Therapeutics (ACRS) reported earnings of -$0.13 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for ACRS's next earnings release expected on November 05, 2025. For the next earning release, we expect the company to report earnings of -$0.13 per share, reflecting a year-over-year decrease of 18.18%.
Earnings History
Price & Consensus
Zacks News for ACRS
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates
ACRS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Misses Revenue Estimates
ACRS FAQs
Based on past history, Zacks believes Aclaris Therapeutics, Inc. (ACRS) will report their next quarter earnings on November 05, 2025. For the next earning release, we expect the company to report earnings of -0.13 per share, reflecting a year-over-year increase of -18.18.
Based on past history, Zacks believes Aclaris Therapeutics, Inc. (ACRS) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on November 05, 2025.
The Zacks Consensus Estimate for Aclaris Therapeutics, Inc. (ACRS) for the quarter ending in September 2025 is $-0.13 a share. We expect Aclaris Therapeutics, Inc. to miss by 6.49%.
In the earnings report for the quarter ending in June 2024, Aclaris Therapeutics, Inc. (ACRS) announced earnings of $-0.15 per share versus the Zacks Consensus Estimate of $-0.19 per share, representing a surprise of -21.05%.